Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells

By Lu Y.   Zi X.   Zhao Y.   Pollak M.  

Biochemical and Biophysical Research Communications, Vol. 313, Iss. 3, 2004-01 ,pp. : 709-715

Elsevier

Access to resources Recommend Favorite

Inhibition of the erbB-2 Tyrosine Kinase Receptor in Breast Cancer Cells by Phosphoromonothioate and Phosphorodithioate Antisense Oligonucleotides

By Vaughn James P.   Demirdji Samuel   Mills Jeffrey K.   Caruthers Marvin H.   Iglehart J. Dirk   Marks Jeffrey R.  

Nucleic Acids Research, Vol. 24, Iss. 22, 1996-11 ,pp. : 4558-4564

Oxford University Press

Access to resources Recommend Favorite

Enhanced Drug Resistance in Cells Coexpressing ErbB2 with EGF Receptor or ErbB3

By Chen X.   Yeung T.K.   Wang Z.  

Biochemical and Biophysical Research Communications, Vol. 277, Iss. 3, 2000-11 ,pp. : 757-763

Elsevier

Access to resources Recommend Favorite

Differential cytoskeletal association of ErbB1 and ErbB2 during keratinocyte differentiation

By Kansra S.   Stoll S.W.   Elder J.T.  

Biochemical and Biophysical Research Communications, Vol. 295, Iss. 5, 2002-08 ,pp. : 1108-1117

Elsevier

Access to resources Recommend Favorite

Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells

By Yumoto Noriko   Yu Xiaomei   Hatakeyama Mariko  

Molecular and Cellular Biochemistry, Vol. 285, Iss. 1-2, 2006-04 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite